semaglutide news oct 26 2025 Older Americans Quit Weight Loss Drugs in Droves Majority of adults with obesity

Wong, PhD, MPH, a professor of medicine at the University of California, Irvine School of Medicine, and colleagues noted that the impact glucagon-like peptide

U posljednjem kolu prvog dijela sezone, NK Kreevo ugostit e ekipu FK Kauna na STAMAL Areni

Zero sugar, no artificial flavouring

Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and chronic kidney disease, according to a new study.

Novo Nordisk has innovated a subcutaneous formulation of semaglutide, branded as Ozempic, which functions as a modified human glucagon-like peptide-1 (GLP-1) analogue

A recent lawsuit alleges that semaglutide and similar medications in the same class may be linked to gastroparesis, a condition characterized by delayed stomach emptying that can have severe consequences for some.